Search clinical trials for: Hair Regrowth

Total 1157 results

Acorn Biolabs Inc.

Enrolling by invitation

Reduction in Symptoms After Laser Therapy With Acorn aHFS

Skin Aging

Canada
Zel Skin and Laser Specialists
Merz Aesthetics Inc.

Active, not recruiting

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

Androgenetic Alopecia

United States
RTI International
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Enrolling by invitation

Early Check: Expanded Screening in Newborns

Primary Hyperoxaluria Type 3 | Diabetes Mellitus | Hemophilia A | Hemophilia B | Hereditary Fructose Intolerance | Cystic Fibrosis | Factor VII Deficiency | Phenylketonurias | Sickle Cell Disease | Dravet Syndrome | Duchenne Muscular Dystrophy | Prader-Willi Syndrome | Fragile X Syndrome | Chronic Granulomatous Disease and other conditions

United States
University of Minnesota

Completed

Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia

Frontal Fibrosing Alopecia | Central Centrifugal Cicatricial Alopecia | Scarring Alopecia | Central Centrifugal Scarring Alopecia | Lichen Planopilaris

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Quaternary Ammonium and Immunization in Hairdressers (AQTIFF)

Hypersensitivity | Quaternary Ammonium

France
Northwestern University

Active, not recruiting

Ice Versus EMLA for Pain in Laser Hair Removal

Hair Removal

United States
Second Affiliated Hospital of Xi'an Jiaotong University

Completed

Efficacy and Safety of 30% Supramolecular Salicylic Acid Combined With Supramolecular Active Zinc in the Treatment of Malassezia Folliculitis

Malassezia Folliculitis

China
Technoderma Medicines Inc.
Therapeutics, Inc.

Completed

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Alopecia, Androgenetic

United States
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (AA)

Alopecia Areata

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Active, not recruiting

A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata (AA)

Alopecia Areata(AA)

China
Eli Lilly and Company

Active, not recruiting

A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Plaque Psoriasis | Psoriatic Arthritis

India
Helsinki University Central Hospital

Completed

Hair Cortisol and Symptoms in Children With Psychopathology During CBT

Child Behavior Problem
Northwestern University

Active, not recruiting

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

Permanent Chemotherapy-induced Alopecia

United States
Amgen

Completed

Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

Alopecia Areata

United States, Canada
Jinnah Hospital

Completed

Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Pakistan
Guy's and St Thomas' NHS Foundation Trust
King's College London; Uppsala University

Active, not recruiting

Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment

Prostate Cancer

United Kingdom
Hoffmann-La Roche

Completed

Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry Study (ESTHER)

Breast Cancer

United Kingdom
LEO Pharma

Completed

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

Frontal Fibrosing Alopecia

United States
AbbVie

Enrolling by invitation

A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

Uterine Fibroids (UF)

United States
Charite University, Berlin, Germany

Completed

Mother - Newborn Observational Study

Skin Microbiome

Germany
Boehringer Ingelheim

Active, not recruiting

Emp-Activity: Empagliflozin Functional Capacity

Heart Failure

Czechia, Switzerland, Poland, Hungary, Romania, Bulgaria
Nutracore
Novarex

Completed

Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health

Hair Damage

Korea, Republic of
University of California, Irvine

Completed

The Utility of Platelet Rich Plasma in Hair Loss

Androgenetic Alopecia

United States
Memorial Sloan Kettering Cancer Center
Yale University; Dana-Farber Cancer Institute

Active, not recruiting

A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia

Leukemia | Leukemia, Hairy Cell | Hairy Cell Leukemia

United States
Walter Reed National Military Medical Center

Terminated

Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial

Pseudofolliculitis Barbae

United States
University Hospitals Cleveland Medical Center

Terminated

Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata

Alopecia Areata

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

Recurrent Adult Burkitt Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Recurrent Chronic Lymphocytic Leukemia | Recurrent Follicular Lymphoma and other conditions

United States
Novartis Pharmaceuticals

Active, not recruiting

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma (ELARA)

Follicular Lymphoma

United States, Spain, Belgium, Japan, Australia, Germany, Italy, Netherlands, Norway, United Kingdom, Austria, France
Stanford University
National Cancer Institute (NCI)

Terminated

Ipilimumab and Local Radiation for Selected Solid Tumors

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
VIST - Faculty of Applied Sciences
Tosla d.o.o.; Slovenian Research and Innovation Agency

Enrolling by invitation

The Effect of 24-week Dietary Intake of Food Supplements on Hair (TO-HAIR)

Hair Loss | Hair Thinning

Slovenia
Chong Kun Dang Pharmaceutical

Completed

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

Alopecia

Korea, Republic of
Institute of Dermatology, Thailand

Enrolling by invitation

Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study (Tofacitinib)

Frontal Fibrosing Alopecia | Lichen Planopilaris

Thailand
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
The Second Hospital of Anhui Medical University
Hefei CAS Ion Medical and Technical Devices Co.,Ltd

Completed

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis (ECAPMF)

Malassezia Folliculitis

China
University Hospital, Brest

Terminated

Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris (PRURIT-ALOPECI)

Alopecia | Lichen Planus

France
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Systemic Mastocytosis | Recurrent... and other conditions

United States
Dr. August Wolff GmbH & Co. KG Arzneimittel
SIT Skin Investigation and Technology Hamburg GmbH

Completed

In-Use Test of a Cosmetic Product in Subjects With Chronically Itchy Scalp

Pruritus of the Scalp

Germany
Legacy Healthcare SA

Completed

Efficacy and Safety of LH-8 in Paediatric Alopecia Areata (AA)

Alopecia Areata | Pediatric Disorder

France, Germany, Bulgaria
NovoBliss Research Pvt Ltd
Collagen Lifesciences Private Limited

Completed

A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments

Healthy | Osteoarthritis, Knee | Brittle Nails | Mild to Moderate Acne | Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1 | Other Specified Diseases of Hair and Hair Follicles

India
Services Institute of Medical Sciences, Pakistan

Completed

Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata

Extensive Alopecia Areata

Pakistan
Memorial Sloan Kettering Cancer Center
University of Chicago; New York University

Active, not recruiting

Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer

Non-Metastatic Breast Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Hairy Cell Leukemia

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

Alopecia | Male Pattern Hair Loss

United States
Dr. Peter C. Friedman

Completed

Cold Plasma to Treat Hair Loss

Androgenetic Alopecia

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed

Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer (HNC-SYSU-005)

Oral Cancer

China
Dermatology Consulting Services, PLLC
Ortho Dermatologics

Completed

A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis

Scalp Psoriasis

United States
Hope Medicine (Nanjing) Co., Ltd

Completed

To Evaluate the Safety, Tolerability and Efficacy in Male and Female With AGA Treated With HMI-115 Over a 24-week Treatment Period

Androgenetic Alopecia

Australia
National Cancer Institute (NCI)

Completed

LMB-2 to Treat Hairy Cell Leukemia

Hairy Cell Leukemia

United States
Candela Corporation

Completed

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus

Onychomycosis | Acne | Wrinkle | Pigmented Lesions | Pseudofolliculitis Barbae | Unwanted Hair | Vascular Lesion

United States
Icahn School of Medicine at Mount Sinai

Completed

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States

Search clinical trials for: Hair Regrowth

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations